Literature DB >> 24840570

Examining Executive Dysfunction with the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS): normative values from a healthy sample and clinical utility in Alzheimer's disease.

Helena S Moreira1, César F Lima2, Selene G Vicente3.   

Abstract

BACKGROUND: The Institute of Cognitive Neurology (INECO) Frontal Screening (IFS) is a brief neuropsychological tool recently devised for the evaluation of executive dysfunction in neurodegenerative conditions.
OBJECTIVE: In this study we present a cross-cultural validation of the IFS for the Portuguese population, provide normative values from a healthy sample, determine how age and education affect performance, and inspect its clinical utility in the context of Alzheimer's disease (AD). A comparison with the Frontal Assessment Battery (FAB) was undertaken, and correlations with other well-established executive functions measures were examined.
METHODS: The normative sample included 204 participants varying widely in age (20-85 years) and education (3-21 years). The clinical sample (n = 21) was compared with a sample of age- and education-matched controls (n = 21). Healthy participants completed the IFS and the Mini-Mental State Examination (MMSE). In addition to these, the patients (and matched controls) completed the FAB and a battery of other executive tests.
RESULTS: IFS scores were positively affected by education and MMSE, and negatively affected by age. Patients underperformed controls on the IFS, and correlations were found with the Clock Drawing Test, Stroop test, and the Zoo Map and Rule Shift Card tests of the Behavioral Assessment of the Dysexecutive Syndrome. A cut-off of 17 optimally differentiated patients from controls. While 88% of the IFS sub-tests discriminated patients from controls, only 67% of the FAB sub-tests did so.
CONCLUSION: Age and education should be taken into account when interpreting performance on the IFS. The IFS is useful to detect executive dysfunction in AD, showing good discriminant and concurrent validities.

Entities:  

Keywords:  Alzheimer's disease; INECO Frontal Screening (IFS); Portuguese norms; cognition; executive dysfunction; screening tests

Mesh:

Year:  2014        PMID: 24840570     DOI: 10.3233/JAD-132348

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  Age-related decline in emotional perspective-taking: Its effect on the late positive potential.

Authors:  Carina Fernandes; A R Gonçalves; R Pasion; F Ferreira-Santos; F Barbosa; I P Martins; J Marques-Teixeira
Journal:  Cogn Affect Behav Neurosci       Date:  2019-02       Impact factor: 3.282

2.  Evaluation of the INECO Frontal Screening and the Frontal Assessment Battery in Peruvian patients with Alzheimer's disease and behavioral variant Frontotemporal dementia.

Authors:  Nilton Custodio; Eder Herrera-Perez; David Lira; María Roca; Facundo Manes; Sandra Báez; Teresa Torralva
Journal:  eNeurologicalSci       Date:  2016-11-03

Review 3.  Assessing Executive Dysfunction in Neurodegenerative Disorders: A Critical Review of Brief Neuropsychological Tools.

Authors:  Helena S Moreira; Ana S Costa; São L Castro; César F Lima; Selene G Vicente
Journal:  Front Aging Neurosci       Date:  2017-11-09       Impact factor: 5.750

4.  Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach.

Authors:  M Belen Bachli; Lucas Sedeño; Jeremi K Ochab; Olivier Piguet; Fiona Kumfor; Pablo Reyes; Teresa Torralva; María Roca; Juan Felipe Cardona; Cecilia Gonzalez Campo; Eduar Herrera; Andrea Slachevsky; Diana Matallana; Facundo Manes; Adolfo M García; Agustín Ibáñez; Dante R Chialvo
Journal:  Neuroimage       Date:  2019-12-10       Impact factor: 6.556

5.  Clinical utility of the INECO Frontal Screening for detecting Mild Cognitive Impairment in Parkinson's disease.

Authors:  Yunier Broche-Pérez; Danay Bartuste-Marrer; Miriam Batule-Domínguez; Filiberto Toledano-Toledano
Journal:  Dement Neuropsychol       Date:  2019 Oct-Dec

6.  Evaluation of sensitivity and specificity of the INECO Frontal Screening and the Frontal Assessment Battery in mild cognitive impairment.

Authors:  Zoylen Fernández-Fleites; Elizabeth Jiménez-Puig; Yunier Broche-Pérez; Sheyla Morales-Ortiz; Darlyn Alejandra Reyes Luzardo; Luis Ramón Crespo-Rodríguez
Journal:  Dement Neuropsychol       Date:  2021 Jan-Mar

7.  Effects of Concomitant Benzodiazepines and Antidepressants Long-Term Use on Social Decision-Making: Results From the Ultimatum Game.

Authors:  Carina Fernandes; Helena Garcez; Senanur Balaban; Fernando Barbosa; Mariana R Pereira; Celeste Silveira; João Marques-Teixeira; Ana R Gonçalves
Journal:  Front Psychol       Date:  2022-06-22

8.  Distinguishing mild cognitive impairment from healthy aging and Alzheimer's Disease: The contribution of the INECO Frontal Screening (IFS).

Authors:  Helena S Moreira; Ana Sofia Costa; Álvaro Machado; São Luís Castro; César F Lima; Selene G Vicente
Journal:  PLoS One       Date:  2019-09-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.